SEC Comment Letter 0000000000-23-011997 to Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc.
Date: Nov. 2, 2023 · CIK: 0001411690 · Accession: 0000000000-23-011997
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275181
Letter
United States securities and exchange commission logo November 2, 2023 R. Erik Holmlin, Ph.D. President and Chief Executive Officer Bionano Genomics, Inc. 9540 Towne Centre Drive, Suite 100 San Diego, California 92121 Re:Bionano Genomics, Inc. Registration Statement on Form S-3 Filed October 26, 2023 File No. 333-275181 Dear R. Erik Holmlin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Su Lian Lu
Show Raw Text
United States securities and exchange commission logo
November 2, 2023
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
Re:Bionano Genomics, Inc.
Registration Statement on Form S-3
Filed October 26, 2023
File No. 333-275181
Dear R. Erik Holmlin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Su Lian Lu